Kevin Reilly has been a member of our Board since 2025 and is a member of our compensation committee. Additionally, Mr. Reilly was a member of the board of directors of our subsidiary, Kestra Medical Technologies, Inc., from 2024 to 2025. Mr. Reilly has been with Ally Bridge Group since 2021 and is a managing director, head of medtech, for the private equity strategy, focused on transactions across healthcare subsectors. From 2014 to 2021, Mr. Reilly was a principal at CRG, a healthcare investment management firm providing growth capital to companies through the form of long-term debt and equity. Mr. Reilly began his career in the Healthcare Investment Banking Group at Stifel. Mr. Reilly received his B.S. in Finance and Information Systems from the University of Maryland. We believe Mr. Reilly is qualified to serve on our Board based on his experience in healthcare investment and management, as well as prior experience as a director of over a dozen medical device companies, including many at a similar stage of development to Kestra.